Arquivamento definitivo - Art. 33 da LPI
#11.1.1
09/26/2023
RPI 2751
Application data
Number
112021023040Type
Filing
Publication
PCT
IB2020054615 The application was abandoned: examination was not requested within the 36 months following the 05/15/2020 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 09/26/2023. We update with every new RPI gazette, published weekly.
Applicants
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
GB
Inventors
R. A. (pessoa física)
US
R. P. (pessoa física)
US
X. C. (pessoa física)
US
IPC Classification
Priority claims
US
62/849,180 · 05/17/2019
US
62/990,093 · 03/16/2020
Abstract
COMPOSIÇÃO DE MATRIZ COMPREENDENDO (S)-5-BENZIL-N-(5- METIL-4-OXO-2,3,4,5-TETRAHIDROBENZO[B][1,4]OXAZEPIN-3-IL)-4H-1,2,4- TRIAZOL-3-CARBOXAMIDA. A presente invenção refere-se a composições farmacêuticas de liberação modificada de um composto inibidor de quinase RIP1 e formas do mesmo, processos ou métodos de preparação de composição e seus usos ou métodos de tratamento.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
09/26/2023
RPI 2751
#11.1
07/11/2023
RPI 2740
#1.3
12/28/2021
RPI 2660
#1.1
11/30/2021
RPI 2656
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.